New Capgemini study points to recovery in the life sciences industry within 24 months; highlights significant changes required to address market challenges

| Press release
Capgemini’s Vision and Reality Report 2009 shows impact of downturn on life sciences sector compounded by ongoing economic and regulatory pressures.

A new report released today by Capgemini, one of the world’s foremost providers of consulting, technology and outsourcing services, highlights the significant challenges faced by the life sciences industry in the current global market. Capgemini’s Vision and Reality Report 2009 provides an in-depth look at the current global market for the life sciences industries including pharmaceutical, medical device, biotech and agribusiness. According to the report, the issues facing the industry are rooted in longer term trends and can therefore be expected to persist long after the upturn, despite the fact that two thirds of life sciences companies interviewed point to a recovery within the next 24 months.